Description of Bixlozone from Watson Biotechnology Co., Ltd

Specifications(COA) of Bixlozone CAS 81777-95-9

Bixlozone is a medication primarily used in the treatment of chronic kidney disease (CKD) and related conditions. It acts as an oral phosphate binder, helping to manage elevated phosphate levels in patients with CKD. By binding to dietary phosphate in the gut, Bixlozone reduces phosphate absorption and helps maintain appropriate phosphate levels in the blood. This can help prevent complications such as bone and mineral disorders associated with CKD.

Founded in 2006 and headquartered in Wuhan, Hubei, China, Watson Biotechnology Co., Ltd is a leading manufacturing powerhouse specializing in the production of Active Pharmaceutical Ingredients (APIs) and Intermediates, Food and Feed Additives, Agricultural and Aquaculture chemicals, and Fine Chemicals. As a dedicated factory, our operations are driven by a commitment to excellence and innovation, ensuring that our products meet the highest standards of quality and compliance.

With a robust team of over 100 skilled professionals, Watson Biotechnology has established itself as a trusted name in the industry. Our products are meticulously crafted to align with international standards such as USP (United States Pharmacopeia), EP (European Pharmacopoeia), and BP (British Pharmacopoeia), guaranteeing reliability and efficacy.

At Watson Biotechnology, we pride ourselves on our cutting-edge facilities and state-of-the-art technology, which enable us to deliver superior products that cater to a diverse range of needs across various sectors. Our dedication to continuous improvement and customer satisfaction drives us to maintain stringent quality control processes and foster an environment of innovation and growth.

Watson Biotechnology Co., Ltd is a professional manufacturer which provide Bixlozone with good quality and best price, welcome to contact us to get COA/TDS/MSDS of Bixlozone.